Patients who received moderate- or high-intensity statin therapy 1 year after revascularization for chronic limb-threatening ischemia were more likely to survive long term, according to data presented at the Society for Vascular Surgery Vascular Annual Meeting.
Nicholas J. Swerdlow, MD, clinical fellow in surgery at Beth Israel Deaconess Medical Center, and colleagues analyzed data from 1,195 patients with chronic limb-threatening ischemia, also known as critical limb ischemia (CLI), who underwent 1,336 first-time revascularization procedures from 2005 to 2014.
This activity is supported by an educational grant from Amgen.
Heart Rhythm Society Scientific Sessions
Search Healio's robust listing of national and international medical meetings.
Tell us what you think about Healio.com »
Get the latest news and education delivered to your inbox
©2018 Healio All Rights Reserved.